Document is current
Any future updates will be listed below
-
Authors
Orji, Ikechukwu A. https://orcid.org/0000-0001-5028-5428
Baldridge, Abigail S.
Omitiran, Kasarachi
Guo, Mainzhao
Ajisegiri, Whenayon Simeon
Ojo, Tunde M.
Shedul, Gabriel
Kandula, Namratha R.
Hirschhorn, Lisa R.
Huffman, Mark D.
Ojji, Dike B.
-
Funding
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (R01HL144708)
- License Information
-
More Information
Article History
Received: 23 September 2020
Accepted: 26 March 2021
First Online: 9 April 2021
Declarations
:
: Written informed consent was obtained from all participants in this study. The study was reviewed by the Northwestern University Institutional Review Board and Health Research Ethics Committees of University of Abuja Teaching Hospital and Federal Capital Territory (FHREC/2019/01/03/16–01-19). All procedures followed were in accordance with the ethical standards of the ethics committees and institutional review board and the Helsinki Declaration of 1975, as revised in 2000.
: Not Applicable.
: Dr. Huffman reports grants from American Heart Association, Verily, AstraZeneca, personal fees from American Medical Association, outside the submitted work. The George Institute for Global Health has a patent, license, and has received investment funding with intent to commercialize fixed-dose combination therapy through its social enterprise business, George Medicines. All other authors declare that they have no competing interests.
